Obesity drug retatrutide targets glucose-dependent insulinotropic polypeptide receptors, glucagon-like peptide-1 receptors and glucagon receptors
Adverse Effect Profile and Safety The most common adverse effects include gastrointestinal intolerance (nausea, vomiting, diarrhea), transient fatigue, and early satiety
Global Journal of Pharmacy & Pharmaceutical Sciences 4:110114 Daquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, Kasse CM, Yan J, Prossnitz AN, Chang E, Baker SW, Hovgaard L, Steensgaard DB, Andersen HB, Simonsen L, Appel EA (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
If exact dosing matters to your decision, ask support for the panel directly before ordering
If you do choose to drink, limit yourself to one standard drink with food, stay well-hydrated, and monitor for heightened nausea
Declared Content: 5mg